共 50 条
Neuroprotection in Huntington's disease
被引:0
作者:
Bonelli, RM
[1
]
Hödl, AK
[1
]
Kapfhammer, HP
[1
]
机构:
[1] Graz Med Univ, Univ Clin Psychiat, A-8036 Graz, Austria
关键词:
D O I:
10.2174/1570180053175133
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Minocycline, the 7-dimethylamino- 6-dimethyl-desoxytetracycline hydrochloride, is a caspase-1 inhibitor and may serve as anti-apoptotic agent, thereby acting neuroprotective. It directly inhibits both caspase-independent and -dependent mitochondrial cell death pathways, and decreases inducible nitric oxide synthetase activity. Minocycline delays disease progression in the transgenic mouse model of Huntington's disease (HD), extending survival by 14%. HD is a late onset relentlessly progressive, neurodegenerative disorder with currently no cures or even effective therapies, death occurring 15 years after onset. In this review, recent clinical and preclinical data on minocycline in HD and neuroprotective alternatives discussed.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 50 条